ライフサイエンスコーパス: human metapneumovirus

1 nfluenza A, respiratory syncytial virus, and human metapneumovirus.

2 ditional methods, primarily rhinoviruses and human metapneumovirus.

3 syncytial virus (RSV), human bocavirus, and human metapneumovirus.

4 ng with acute respiratory tract illness, for human metapneumovirus.

5 man seasonal coronavirus, parainfluenza, and human metapneumovirus.

6 ons were seen among sequences of the related human metapneumovirus.

7 uses were less frequent overall, followed by human metapneumoviruses.

8 3), adenovirus (2), parainfluenza 4 (1), and human metapneumovirus (1).

9 vs. 8%), as were adenovirus (15% vs. 3%) and human metapneumovirus (15% vs. 8%).

10 us HKU1, coronavirus NL63, coronavirus OC43, human metapneumovirus A and B, influenza A, influenza A

11 Human metapneumovirus, a leading cause of respiratory tr

12 did not significantly affect infection with human metapneumovirus, a related virus.

13 arainfluenza viruses 1-4, influenza A and B, human metapneumovirus, adenovirus, and human rhinoviruse

14 ruses; parainfluenza viruses 1, 2, 3, and 4; human metapneumovirus; adenovirus; enterovirus-rhinoviru

15 uses 1-3, influenza viruses AH1, AH3, and B, human metapneumovirus, adenoviruses, and bocavirus) and

16 rus, as well as respiratory syncytial virus, human metapneumovirus, adenoviruses, picornaviruses, and

17 influenza, respiratory syncytial virus, and human metapneumovirus among patients with CAP of all age

18 G proteins from other subtype C viruses and human metapneumovirus and more than 170 aa larger than t

19 l data for two other respiratory pathogens - human metapneumovirus and seasonal coronavirus - from 35

20 irus, parainfluenza virus types 1 and 3, and human metapneumovirus) and identified predictors of supe

21 i) respiratory syncytial viruses A and B and human metapneumovirus, and (iii) parainfluenza virus typ

22 cal tests, including rhinovirus/enterovirus, human metapneumovirus, and coronavirus.

23 human coronaviruses, parainfluenza viruses, human metapneumovirus, and enteroviruses but not respira

24 of human rhinoviruses, human coronaviruses, human metapneumovirus, and human bocavirus, as well as t

25 ses (influenza, respiratory syncytial virus, human metapneumovirus, and human rhinovirus) in a recons

26 Coronaviruses, human metapneumovirus, and influenza A detections were u

27 luenza viruses, respiratory syncytial virus, human metapneumovirus, and the deadly zoonotic henipavir

28 including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus.

29 novirus, seasonal coronavirus, picornavirus, human metapneumovirus, and/or SARS-CoV-2 rapid antigen t

30 Viral LRIs from rhinoviruses and human metapneumovirus are increasingly detected in child

31 s.IMPORTANCE Respiratory syncytial virus and human metapneumovirus are leading causes of respiratory

32 continued efforts to improve the outcome of human metapneumovirus-associated ALRI among young infant

33 obally, there were an estimated 14.2 million human metapneumovirus-associated ALRI cases (uncertainty

34 and 16 100 overall (hospital and community) human metapneumovirus-associated ALRI deaths (5700 to 88

35 sociated ALRI in-hospital deaths and overall human metapneumovirus-associated ALRI deaths (both in-ho

36 We aimed to estimate the age-stratified human metapneumovirus-associated ALRI global incidence,

37 We also estimated human metapneumovirus-associated ALRI in-hospital deaths

38 countries are at greater risk of death from human metapneumovirus-associated ALRI than older childre

39 ed incidence and hospital admission rates of human metapneumovirus-associated ALRI to population esti

40 in-hospital case-fatality ratios (hCFRs) of human metapneumovirus-associated ALRI using a generalise

41 We estimated the global burden of human metapneumovirus-associated ALRIs in children young

42 hospital admissions, and deaths by combining human metapneumovirus-associated burden estimates and at

43 [UR] 10.2 million to 20.1 million), 643 000 human metapneumovirus-associated hospital admissions (UR

44 tal admissions (UR 425 000 to 977 000), 7700 human metapneumovirus-associated in-hospital deaths (260

45 Additionally, we estimated human metapneumovirus-attributable ALRI cases, hospital

46 ed by parainfluenza virus 3, influenza B and human metapneumovirus B.

47 uman metapneumovirus in laboratory-confirmed human metapneumovirus cases and deaths.

48 enterovirus (82/556, 14.7%), coronavirus and human metapneumovirus (each 32/556, 5.6%).

49 ral activity against RSV (EC(50) = 3-46 nM), human metapneumovirus (EC(50) = 210 nM), human rhinoviru

50 The prefusion conformation of human metapneumovirus fusion protein (hMPV Pre-F) is cri

51 CARV screening (OR 4.27), RSV (OR 2.46), and human metapneumovirus (HMPV) (OR 2.76).

52 The severity of the disease burden of human metapneumovirus (HMPV) among older adults is less

53 family Paramyxoviridae includes two members, human metapneumovirus (hMPV) and avian metapneumovirus (

54 Coronaviruses, human metapneumovirus (hMPV) and enteroviruses have also

55 Human metapneumovirus (HMPV) and human parainfluenza vir

56 Human metapneumovirus (HMPV) and human parainfluenza vir

57 n severe bronchiolitis and dual infection by human metapneumovirus (hMPV) and human respiratory syncy

58 inflammatory chemokine production induced by human metapneumovirus (hMPV) and Nipah virus (NiV), sugg

59 Human metapneumovirus (hMPV) and respiratory syncytial v

60 act infections caused by the paramyxoviruses human metapneumovirus (hMPV) and respiratory syncytial v

61 coproteins derived from two human pathogens, human metapneumovirus (hMPV) and respiratory syncytial v

62 Human metapneumovirus (hMPV) and respiratory syncytial v

63 Understanding the seasonality of human metapneumovirus (hMPV) and respiratory syncytial v

64 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are closely related pathoge

65 n respiratory syncytial virus (hRSV) and the human metapneumovirus (hMPV) are important human respira

66 virus (RSV), parainfluenza virus (PIV), and human metapneumovirus (hMPV) are increasingly associated

67 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are two closely related vir

68 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are two important viral pat

69 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are two of the leading caus

70 like influenza, information on the burden of human metapneumovirus (HMPV) as a cause of hospitalizati

71 Here, using human metapneumovirus (HMPV) as a model, we demonstrate

72 Human metapneumovirus (hMPV) belongs to the Pneumovirida

73 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) cause a similar spectrum of

74 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) cause acute respiratory inf

75 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) cause human respiratory dis

76 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) cause severe respiratory di

77 Human metapneumovirus (HMPV) causes lower respiratory tr

78 Human metapneumovirus (HMPV) causes significant upper an

79 The M2 gene of human metapneumovirus (HMPV) contains two overlapping op

80 ngly, GFP-expressing AMPV and GFP-expressing human metapneumovirus (HMPV) could be recovered using th

81 DS-Cav1 vaccination also activated human metapneumovirus (HMPV) cross-reactive B cells capa

82 Human metapneumovirus (HMPV) encodes three glycoproteins

83 Human metapneumovirus (hMPV) epidemiology, clinical char

84 In contrast, human metapneumovirus (HMPV) expressing only the F prote

85 The phosphoprotein of human metapneumovirus (HMPV) forms homotetramers compose

86 HPIV), respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) from the 52060 respiratory

87 The human metapneumovirus (hMPV) fusion (F) protein is essen

88 Human metapneumovirus (HMPV) has been identified as a wo

89 Human metapneumovirus (HMPV) has emerged as an important

90 toward understanding the immune response to human metapneumovirus (hMPV) has lagged behind, although

91 Human metapneumovirus (HMPV) has recently been identifie

92 competent adult with asthma developed severe human metapneumovirus (HMPV) illness complicated by grou

93 competent adult with asthma developed severe human metapneumovirus (HMPV) illness complicated by grou

94 uenza, respiratory syncytial virus (RSV), or human metapneumovirus (hMPV) illness had pneumococcus de

95 imated respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) illness incidences among pr

96 de-PLx system resulted from the detection of human metapneumovirus (HMPV) in 9 specimens, human CoV (

97 den of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) in older adults in comparis

98 nts (ASRs) (bioMerieux) for the detection of human metapneumovirus (hMPV) in respiratory samples.

99 ntibody MAb-8 was evaluated for detection of human metapneumovirus (HMPV) in shell vial centrifugatio

100 n immunocompromised hosts, but the impact of human metapneumovirus (hMPV) in this setting was previou

101 Recombinant human metapneumovirus (HMPV) in which the SH, G, or M2 g

102 The inpatient and outpatient burden of human metapneumovirus (HMPV) infection among young child

103 Identified in 2001, human metapneumovirus (hMPV) infection can lead to hospi

104 We determined the prevalence of human metapneumovirus (hMPV) infection in adults with as

105 We aimed to compare the characteristics of human metapneumovirus (hMPV) infection with influenza A

106 derstanding temporal trends of influenza and human metapneumovirus (HMPV) infections among adults and

107 Human metapneumovirus (hMPV) infections have a significa

108 Unlike influenza, information on the risk of human metapneumovirus (HMPV) infections in adults with c

109 The clinical and genomic epidemiology of human metapneumovirus (hMPV) infections in community set

110 sk factors for poor outcomes associated with human metapneumovirus (hMPV) infections in recipients of

111 Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) infections pose a significa

112 IMPORTANCE Human metapneumovirus (HMPV) infects global populations,

113 Human metapneumovirus (HMPV) is a common and globally pr

114 Human metapneumovirus (hMPV) is a common pathogen causin

115 Human metapneumovirus (hMPV) is a frequent cause of acut

116 Human metapneumovirus (hMPV) is a frequent cause of bron

117 Human metapneumovirus (HMPV) is a leading cause of acute

118 Human metapneumovirus (HMPV) is a leading cause of acute

119 Human metapneumovirus (hMPV) is a leading cause of acute

120 Human metapneumovirus (HMPV) is a leading cause of acute

121 Human metapneumovirus (HMPV) is a leading cause of acute

122 Human metapneumovirus (HMPV) is a leading cause of acute

123 Human metapneumovirus (HMPV) is a leading cause of acute

124 Human metapneumovirus (HMPV) is a leading cause of lower

125 Human metapneumovirus (hMPV) is a leading cause of morbi

126 Human metapneumovirus (HMPV) is a leading cause of respi

127 Human metapneumovirus (hMPV) is a leading cause of respi

128 Human metapneumovirus (HMPV) is a leading cause of respi

129 Human metapneumovirus (HMPV) is a leading cause of respi

130 Human metapneumovirus (HMPV) is a leading cause of respi

131 Human metapneumovirus (hMPV) is a leading cause of respi

132 Human metapneumovirus (hMPV) is a leading cause of viral

133 Human metapneumovirus (hMPV) is a major causative agent

134 Human metapneumovirus (HMPV) is a major cause of respira

135 Human metapneumovirus (HMPV) is a major cause of respira

136 Human metapneumovirus (HMPV) is a major cause of respira

137 Human metapneumovirus (hMPV) is a major cause of upper a

138 Human metapneumovirus (HMPV) is a major etiologic agent

139 Human metapneumovirus (HMPV) is a major worldwide respir

140 Human metapneumovirus (hMPV) is a member of the Pneumovi

141 Human metapneumovirus (HMPV) is a negative-strand RNA vi

142 Human metapneumovirus (hMPV) is a newly described paramy

143 Human metapneumovirus (hMPV) is a newly discovered param

144 Human metapneumovirus (hMPV) is a newly identified human

145 Human metapneumovirus (hMPV) is a nonsegmented, single-s

146 Human metapneumovirus (HMPV) is a paramyxovirus that cau

147 Human metapneumovirus (hMPV) is a pathogen of worldwide

148 Human metapneumovirus (HMPV) is a recently described hum

149 Human metapneumovirus (hMPV) is a recently described mem

150 Human metapneumovirus (hMPV) is a recently described par

151 Human metapneumovirus (hMPV) is a recently described par

152 Human metapneumovirus (hMPV) is a recently described par

153 Human metapneumovirus (hMPV) is a recently discovered pa

154 Human metapneumovirus (hMPV) is a recently discovered pa

155 e important clinical implications.IMPORTANCE Human metapneumovirus (HMPV) is a recently discovered pa

156 Human metapneumovirus (hMPV) is a recently discovered re

157 Human metapneumovirus (hMPV) is a recently discovered vi

158 Human metapneumovirus (hMPV) is a relatively recently id

159 Human metapneumovirus (hMPV) is a respiratory paramyxovi

160 Human metapneumovirus (hMPV) is a respiratory paramyxovi

161 Human metapneumovirus (hMPV) is a respiratory virus dete

162 Human metapneumovirus (hMPV) is a significant cause of a

163 Human metapneumovirus (HMPV) is a significant respirator

164 The recently identified human metapneumovirus (HMPV) is a worldwide respiratory

165 The M2-1 protein of human metapneumovirus (HMPV) is a zinc-binding transcrip

166 Human metapneumovirus (hMPV) is an important cause of ac

167 IMPORTANCE Human metapneumovirus (hMPV) is an important cause of vi

168 Human metapneumovirus (HMPV) is now recognized to cause

169 uman respiratory syncytial virus (hRSV), the human metapneumovirus (hMPV) is one of the leading cause

170 Human metapneumovirus (hMPV) is one of the major causati

171 den of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) LRTI in premature children

172 A Light Diagnostics human metapneumovirus (HMPV) monoclonal antibody reagent

173 structural homology between the hRSV and the human metapneumovirus (hMPV) N(0)-P complexes.

174 The role that human metapneumovirus (hMPV) plays in the etiology of up

175 cterium effector proteins and SARS-CoV-2 and human metapneumovirus (HMPV) proteins in yeast to test t

176 The burden of severe human metapneumovirus (HMPV) respiratory tract infection

177 on by challenging B cell-deficient mice with human metapneumovirus (HMPV) several weeks after primary

178 Human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV) share virologic and epidemi

179 Human metapneumovirus (hMPV) significantly impacts young

180 A microarray (Virochip) was used to detect a human metapneumovirus (hMPV) strain associated with a cr

181 he CAN98-75 (CAN75) and the CAN97-83 (CAN83) human metapneumovirus (HMPV) strains, which represent th

182 eavage activation of the fusion F protein of human metapneumovirus (HMPV) to replication and pathogen

183 kine production by BALB/c mice infected with human metapneumovirus (hMPV) was compared to respiratory

184 Human metapneumovirus (hMPV) was identified in 2001 as a

185 Human metapneumovirus (HMPV) was initially identified as

186 Human metapneumovirus (HMPV) was recently identified in

187 Chimeric versions of recombinant human metapneumovirus (HMPV) were generated by replacing

188 ed the capability of MS for the detection of human metapneumovirus (HMPV), a common cause of respirat

189 Human metapneumovirus (hMPV), a member of the family Par

190 Human metapneumovirus (hMPV), a recently described param

191 Human metapneumovirus (hMPV), a recently discovered para

192 Human metapneumovirus (HMPV), a recently discovered para

193 Human metapneumovirus (hMPV), a recently discovered resp

194 piratory syncytial virus (RSV), enterovirus, human metapneumovirus (hMPV), adenovirus (AdV), and rhin

195 enza virus (Flu), parainfluenza virus (PIV), human metapneumovirus (HMPV), adenovirus (AdV), rhinovir

196 Human metapneumovirus (HMPV), an emerging pathogen of th

197 Respiratory syncytial virus (RSV), human metapneumovirus (HMPV), and human parainfluenza vi

198 of Mononegavirales, namely, VSV, RABV, HRSV, human metapneumovirus (HMPV), and human parainfluenza vi

199 es human respiratory syncytial virus (hRSV), human metapneumovirus (hMPV), and human parainfluenza vi

200 ted to influenza B virus, influenza A virus, human metapneumovirus (HMPV), and respiratory syncytial

201 ivatives of the CAN97-83 clinical isolate of human metapneumovirus (HMPV), consensus nucleotide seque

202 Human metapneumovirus (HMPV), first identified in 2001,

203 A recently discovered paramyxovirus, human metapneumovirus (hMPV), has been studied by our gr

204 Paramyxoviruses, including human metapneumovirus (HMPV), have evolved mechanisms to

205 ts: adenovirus, coronaviruses HKU1 and NL63, human metapneumovirus (hMPV), influenza A virus (to type

206 gnosis of respiratory syncytial virus (RSV), human metapneumovirus (HMPV), parainfluenza virus 1 to 3

207 Human metapneumovirus (HMPV), recently identified in iso

208 espiratory syncytial virus (RSV), influenza, human metapneumovirus (HMPV), rhinovirus, and human para

209 u-A, Flu-B, PIV-1, PIV-2, PIV-3, PIV-4, RSV, human metapneumovirus (hMPV), rhinoviruses (RhVs), enter

210 (RSV), Human Parainfluenza Virus (HPIV), and Human Metapneumovirus (hMPV), we adopt a theoretical app

211 or respiratory syncytial virus (RSV) but not human metapneumovirus (HMPV).

212 tory syncytial virus (RSV), mumps virus, and human metapneumovirus (HMPV).

213 al virus (RSV), coronavirus OC43 (OC43), and human metapneumovirus (HMPV).

214 HCoV) OC43, 229E, NL63, and HKU1 (5.3%); and human metapneumovirus (HMPV; 5.0%).

215 man respiratory syncytial viruses (HRSV) and human metapneumoviruses (HMPV) were involved in the etio

216 Human metapneumovirus (HMPVi) and parainfluenza virus (P

217 Human metapneumoviruses (HMPVs) are recently identified

218 ciency virus, human parainfluenza virus 1-4, human metapneumovirus, human coronaviruses (229E/OC43/NL

219 s such as human respiratory syncytial virus, human metapneumovirus, human parainfluenza virus type 3,

220 ral infections (respiratory syncytial virus, human metapneumovirus, human rhinovirus, and adenovirus)

221 We also detected human metapneumovirus in 15 percent of samples from 261

222 0 to 61 600) could be causally attributed to human metapneumovirus in 2018.

223 ates are available for ALRIs associated with human metapneumovirus in children, and no licensed vacci

224 rden estimates and attributable fractions of human metapneumovirus in laboratory-confirmed human meta

225 We sought to determine the role of human metapneumovirus in lower respiratory tract illness

226 panzees during the cohort study, we detected human metapneumovirus in two chimpanzees from a February

227 p complex of respiratory syncytial virus and human metapneumovirus incorporate GS-646939 and ATP with

228 The mean age of human metapneumovirus-infected children was 11.6 months,

229 g TCD8 to functional spleen TCD8 in the same human metapneumovirus-infected mice.

230 Human metapneumovirus infection in the lower respiratory

231 We now find that human metapneumovirus infection induces virus-specific l

232 Human metapneumovirus infection is a leading cause of re

233 compared the gene expression of TCD8 during human metapneumovirus infection to those in acute or chr

234 have disproportionately high risks of severe human metapneumovirus infections across all World Bank i

235 and no licensed vaccines or drugs exist for human metapneumovirus infections.

236 table by both commercial assays (adenovirus, human metapneumovirus, influenza A virus, influenza B vi

237 005 and 2013: adenovirus, human coronavirus, human metapneumovirus, influenza B virus and respiratory

238 he primary analysis tested negative for RSV, human metapneumovirus, influenza, and severe acute respi

239 Human metapneumovirus is a common virus associated with

240 Human metapneumovirus is a major cause of respiratory tr

241 Human metapneumovirus is now recognized as a cause of lo

242 cture and activities of CR-VI+, a portion of human Metapneumovirus L consisting of CR-VI and the poor

243 ay epithelial cells or mice with recombinant human metapneumovirus lacking SH expression (rhMPV-Delta

244 SARS-CoV-2 nucleocapsid protein and human metapneumovirus M2-1 protein are shown to enhance

245 Human metapneumovirus may compound the clinical severity

246 us types 1, 2, and 3 (PIV1, PIV2, and PIV3), human metapneumovirus (MPV), and adenovirus (AdV) in 1,1

247 urred in 2022/2023, particularly for RSV and human metapneumovirus (n = 377 vs 93-127).

248 workup (respiratory syncytial virus [n = 3], human metapneumovirus [n = 1], and human coronavirus NL6

249 utine clinical testing (influenza A [n = 3], human metapneumovirus [n = 2], and human coronavirus OC4

250 tory syncytial virus, influenza viruses, and human metapneumovirus, often implicated as co-pathogens

251 e found that PD-L1(-/-) mice challenged with human metapneumovirus or influenza showed a similar leve

252 tribute to TCD8 impairment induced by either human metapneumovirus or influenza virus infection.

253 red acutely in mice following infection with human metapneumovirus or influenza virus.

254 otal of 37 719 incident infections with RSV, human metapneumovirus, or human coronaviruses 229E, NL63

255 er viruses (ie, respiratory syncytial virus, human metapneumovirus, parainfluenza virus, and influenz

256 bacterium effector proteins, SARS-CoV-2 and human metapneumovirus proteins in yeast to test their ef

257 luenza viruses, coronavirus, rhinovirus, and human metapneumovirus, represent a considerable global h

258 missed by the diagnostic panel (rhinovirus, human metapneumovirus, respiratory syncytial virus and p

259 nfluenza virus, coronaviruses, rhinoviruses, human metapneumovirus, respiratory syncytial virus, para

260 of respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus, and influenza virus b

261 f these 248 specimens (20 percent) contained human metapneumovirus RNA or viable virus.

262 -negative LRTD events that were negative for human metapneumovirus, SARS-CoV-2, and influenza, and po

263 variation patterns, which were also seen in human metapneumovirus sequences, point to previously def

264 culture but does not inhibit Sendai virus or human metapneumovirus, two paramyxoviruses.

265 Human metapneumovirus virus (hMPV) is a newly discovered

266 Human metapneumovirus was detected in BAL specimens from

267 A viral cause other than human metapneumovirus was determined for 279 of 687 visi

268 human parainfluenza virus, adenoviruses, and human metapneumovirus was lower in 2020 than 2019.

269 Human metapneumovirus was the commonest virus detected.

270 influenza, respiratory syncytial virus, and human metapneumovirus were substantially more common in

271 iratory tract illnesses were attributable to human metapneumovirus, which means that 12 percent of al